State Street Corp Sells 13,919 Shares of National Health Investors, Inc. (NYSE:NHI)

State Street Corp lowered its stake in National Health Investors, Inc. (NYSE:NHI) by 0.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,860,717 shares of the real estate investment trust’s stock after selling 13,919 shares during the period. State Street Corp owned 4.10% of National Health Investors worth $158,079,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Quarry LP bought a new stake in National Health Investors in the third quarter valued at $27,000. Covestor Ltd boosted its holdings in National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 405 shares in the last quarter. Point72 DIFC Ltd bought a new stake in National Health Investors in the third quarter valued at $35,000. Loomis Sayles & Co. L P bought a new stake in National Health Investors in the third quarter valued at $38,000. Finally, International Assets Investment Management LLC bought a new stake in shares of National Health Investors during the 2nd quarter valued at $36,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

NHI opened at $72.70 on Friday. The stock has a 50-day moving average price of $77.01 and a 200-day moving average price of $75.37. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The firm has a market cap of $3.30 billion, a PE ratio of 24.98, a P/E/G ratio of 4.87 and a beta of 1.04. National Health Investors, Inc. has a 1 year low of $51.59 and a 1 year high of $86.13.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.08 EPS. Sell-side analysts predict that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.95%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is 123.71%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on NHI. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their target price for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Truist Financial boosted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Finally, Bank of America began coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $76.33.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.